| User's Publication |
|
7034
Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K.
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
Sci Rep
2017
7:45768
PubMed ID: 28361969
|
|
7592
Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H.
Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses.
Int J Nanomedicine
2012
6:3295-307
PubMed ID: 22228997
|
|
7727
Asakura K, Izumi Y, Yamamoto M, Yamauchi Y, Kawai K, Serizawa A, Mizushima T, Ohmura M, Kawamura M, Wakui M, Adachi T, Nakamura M, Suematsu M, Nomori H.
The cytostatic effects of lovastatin on ACC-MESO-1 cells.
J. Surg. Res.
2011
170:e197-209
PubMed ID: 21816418
|
|
7784
Yamauchi Y, Izumi Y, Asakura K, Fukutomi T, Serizawa A, Kawai K, Wakui M, Suematsu M, Nomori H.
Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells.
Biochem. Biophys. Res. Commun.
2011
410:328-32
PubMed ID: 21672521
|
|
8088
Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T.
Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.
Int. J. Cancer
2010
129:1005-17
PubMed ID: 20949562
|
|
8186
Tsuji S, Tsuura Y, Morohoshi T, Shinohara T, Oshita F, Yamada K, Kameda Y, Ohtsu T, Nakamura Y, Miyagi Y.
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Br. J. Cancer
2010
103:517-23
PubMed ID: 20628387
|
|
8199
Hasegawa S, Koshikawa-Yano M, Saito S, Morokoshi Y, Furukawa T, Aoki I, Saga T.
Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging.
Int. J. Cancer
2010
128:2138-46
PubMed ID: 20617513
|
|
8379
Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Int. J. Cancer
2010
127:1948-57
PubMed ID: 20104519
|
|
9731
Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O.
Establishment of anti-mesothelioma monoclonal antibodies.
BMC Res Notes
2016
9:324
PubMed ID: 27342200
|
|
10679
Yoneda K, Chikaishi Y, Kuwata T, Ohnaga T, Tanaka F.
Capture of mesothelioma cells with 'universal' CTC-chip.
Oncol Lett
2018
15:2635-2640
PubMed ID: 29434985
|
|
11207
Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
Biochem. Biophys. Res. Commun.
2018
PubMed ID: 30197002
|
|
11107
Xu D, Liang SQ, Yang H, Luthi U, Riether C, Berezowska S, Marti TM, Hall SRR, Bruggmann R, Kocher GJ, Schmid RA, Peng RW.
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Br. J. Cancer
2018
PubMed ID: 29921948
|
|
11217
Matsuura R, Kaji H, Tomioka A, Sato T, Narimatsu H, Moriwaki Y, Misawa H, Imai K, Tsuji S.
Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1.
Sci Rep
2018
PubMed ID: 30250045
|
|
4469
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y.
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
Front Oncol
2018
8:446
PubMed ID: 30406026
|
Back
Top
CELL BANK Website